Praxis Precision Medicines Inc
NASDAQ:PRAX

Watchlist Manager
Praxis Precision Medicines Inc Logo
Praxis Precision Medicines Inc
NASDAQ:PRAX
Watchlist
Price: 38.55 USD 0.26% Market Closed
Market Cap: 777.2m USD

Wall Street
Price Targets

PRAX Price Targets Summary
Praxis Precision Medicines Inc

Wall Street analysts forecast PRAX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRAX is 101.26 USD with a low forecast of 28.28 USD and a high forecast of 283.5 USD.

Lowest
Price Target
28.28 USD
27% Downside
Average
Price Target
101.26 USD
163% Upside
Highest
Price Target
283.5 USD
635% Upside
Praxis Precision Medicines Inc Competitors:
Price Targets
SOBI
Swedish Orphan Biovitrum AB (publ)
19% Upside
ELUT
Elutia Inc
325% Upside
RYTM
Rhythm Pharmaceuticals Inc
32% Upside
GNFT
Genfit SA
143% Upside
IVACC
Intervacc AB
572% Upside
4974
Takara Bio Inc
33% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
14% Downside
ZBIO
Zenas Biopharma Inc
246% Upside

Revenue
Forecast

Revenue Estimate
Praxis Precision Medicines Inc

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 3 years is 78%.

N/A
Past Growth
78%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Praxis Precision Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Praxis Precision Medicines Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRAX's stock price target?
Price Target
101.26 USD

According to Wall Street analysts, the average 1-year price target for PRAX is 101.26 USD with a low forecast of 28.28 USD and a high forecast of 283.5 USD.

What is Praxis Precision Medicines Inc's Revenue forecast?
Projected CAGR
78%

The compound annual growth rate of Praxis Precision Medicines Inc's revenue for the next 3 years is 78%.

Back to Top